American retailer CVS Health has completed the acquisition of Target’s pharmacy and clinics business for about $1.9bn.

CVS Health will own 1,672 pharmacies of Target across 47 states in the US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company intends to brand the acquired pharmacies as CVS/pharmacy. The rebranded pharmacies will operate in a store-within-store format.

A CVS/pharmacy will be established in all Target stores to provide pharmacy services. CVS Health intends to open about 20 new clinics within the Target stores in the coming years.

CVS Health will also rebrand 79 of Target’s clinics as MinuteClinic. The rebranding of the pharmacies and clinics is expected to be completed in a timeframe of six to eight months.

CVS Health president and CEO said Larry Merlo said: “We look forward to helping Target guests on their path to better health through CVS Health’s leading clinical programs, such as Maintenance Choice, Pharmacy Advisor and Specialty Connect.

“In addition, with the Target acquisition we will leverage our unique integrated business model and our scale to drive incremental sales volume and operating profit for the enterprise while providing convenience and cost savings to consumers and payors.”

The transaction is expected to reflect in Target’s fourth quarter 2015 financial results estimating a pre-tax gain of $575m to $775m, based on the final valuation of the divested assets.